Patients with PCD should continue L-carnitine therapy
May not be long-term safe: There is a glaring lack of evidence supporting their long-term safety and efficacy
None of these routes has been characterized in published human pharmacokinetic studies
Considering the central role of glucose catabolism for stimulus-secretion coupling in -cells, our findings suggest that chronic GLP-1 actions on insulin secretion include elevated -cell glucose metabolism
Athletes: for recovery, endurance, and injury prevention Surgical patients: to heal incisions, scars, and soft tissue damage Functional medicine patients: for autoimmune, gut, and inflammation protocols Biohackers: for general regeneration, tissue repair, and neuroprotection What the Research Says A 2018 study found that peptide therapy accelerated the healing of tendons and ligaments
In an early phase study, the combination of trametinib and atezolizumab against BRAF-wild-type melanoma showed promising outcomes in patients